Recent developments in immunotherapy of acute myeloid leukemia. - Wikidata - wikimedia - TriplyDB

Recent developments in immunotherapy of acute myeloid leukemia.

Recent developments in immunotherapy of acute myeloid leukemia.

http://www.wikidata.org/entity/Q38661895

about

Long non-coding RNA AFAP1-AS1 is a novel biomarker in various cancers: a systematic review and meta-analysis based on the literature and GEO datasets.Advances in targeted therapy for acute myeloid leukaemia.Immune checkpoint molecules in acute myeloid leukaemia: managing the double-edged sword.CAR-T cells targeting CLL-1 as an approach to treat acute myeloid leukemia.Protein kinase inhibitors for acute leukemia.Pilot Study on Mass Spectrometry-Based Analysis of the Proteome of CD34⁺CD123⁺ Progenitor Cells for the Identification of Potential Targets for Immunotherapy in Acute Myeloid Leukemia.Update of ALDH as a Potential Biomarker and Therapeutic Target for AML.Bone marrow CD8 T cells express high frequency of PD-1 and exhibit reduced anti-leukemia response in newly diagnosed AML patients.Compound CAR T-cells as a double-pronged approach for treating acute myeloid leukemia.Targeting FLT3 in acute myeloid leukemia using ligand-based chimeric antigen receptor-engineered T cells.Acute myeloid leukemia chimeric antigen receptor T-cell immunotherapy: how far up the road have we traveled?T cell senescence and CAR-T cell exhaustion in hematological malignancies.A Novel Anti-LILRB4 CAR-T Cell for the Treatment of Monocytic AML Therapeutic vaccination with 4-1BB co-stimulation eradicates mouse acute myeloid leukemia Molecular landscape and targeted therapy of acute myeloid leukemia

P2860

Q47108768-2AB0D267-3078-4156-8A68-9F08FBE9CEA8 Q48204144-97EC7D41-AF3C-4D73-A732-C642FF293893 Q48273861-82BE1ABE-EBAC-43A3-B3B6-35980E409F42 Q49168672-BF1E9929-5757-4389-8E42-CC40B6B4735B Q49873905-76E10F67-3A75-43B2-88E0-8C6194E338A8 Q50033703-E2213521-0748-4A80-B8F2-2FB579EC9CB2 Q50416684-CFC92FAF-02E1-483C-A108-B1B10B5106FD Q52725128-C4D0E788-25FA-412F-BE7E-1FBF1E68842A Q52728078-D4922D12-9845-47C3-9C23-39DEE0728107 Q54979939-37897409-0C47-48E8-BDD7-044CAB154A7C Q55292778-CA1B4F99-EC6B-490E-B512-2CDCC9004FCB Q55618747-BD89CC72-6901-4173-A349-F1AC85C577DF Q57039806-B439F2CC-CF95-4B3A-A4DE-2B4E73700DA6 Q57138588-1B6129C2-256A-4335-8FB9-970DF15FAD37 Q59130314-FC3807E1-38A2-444E-A492-8C130540F346

P2860

Recent developments in immunotherapy of acute myeloid leukemia.

http://www.wikidata.org/entity/Q38661895

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Recent developments in immunotherapy of acute myeloid leukemia.

@en

type

label

Recent developments in immunotherapy of acute myeloid leukemia.

@en

prefLabel

Recent developments in immunotherapy of acute myeloid leukemia.

@en

P1433

Q38661895-2AD8AFE2-EAA5-467D-BB7D-3BD8848A749F

P1476

Q38661895-95D98779-1C0F-46D1-A326-6CE57084358C

P2093

Q38661895-0F1381B5-175C-4BE8-BDC7-D4C877DEAE02

Q38661895-27FAC34F-00C7-4C01-A19B-82F16DE379DF

Q38661895-3920F338-E751-4B93-B425-7014B39F5032

Q38661895-54B2FDF9-5C05-4FF4-8C3A-AEC6F001BBFC

Q38661895-9152BE68-9F17-4D1A-9B79-B128B9F9E3B0

P275

Q38661895-53076E14-B42A-4653-9F88-ED7937639521

P2860

Q38661895-027A7ACA-CCAC-41E8-8CA8-5D39FD1E2985

Q38661895-06D3A068-D94F-4B8C-9CAB-FCA3433984D9

Q38661895-083196B5-E90D-4060-A9FC-ABDA82006DAE

Q38661895-0888325A-3001-4841-97BC-5B8FBE8A33B8

Q38661895-0BEF7217-A2B4-4F0F-B4A6-6CFBECACB37E

Q38661895-0C81A68A-A300-408D-8DA5-DB302A3009A7

Q38661895-0D6E1F56-F9B8-4FCA-A53F-72A504F99F98

Q38661895-0FEFDB29-0117-4A37-A8F8-F49B5166A399

Q38661895-10D71E08-4AB1-4E32-BF5D-F98D08238396

Q38661895-114C9CB4-0FB3-4014-8085-D4BCD47370A6

P2888

Q38661895-14AEE6C2-2865-401D-B2F3-07C02941726C

P304

Q38661895-53D5F025-C590-4AF8-8080-D5FABAFD4D5E

P31

Q38661895-15F06283-2957-4572-BF8B-F4477701AB74

Q38661895-5000E464-2704-4710-9FEF-54CDC8251492

P356

Q38661895-2C2D0E62-4D18-43FD-8BEA-D1003B9D279C

P433

Q38661895-D6C739B8-948B-49E9-9F5C-17CD74EA9211

P478

Q38661895-1B05E7AA-72BA-4FE1-BA1C-A8DF25DEE6CD

P5008

Q38661895-A8DE21AE-C013-4ACD-8CAD-F0891FC206BB

P577

Q38661895-1774A199-C72A-4C98-9056-4083D50CFCED

P6179

Q38661895-EE451A18-62D9-4DA4-86C2-6754292863C8

P698

Q38661895-BC06B8FA-39DF-4A23-B665-5E54E7165DB4

P921

Q38661895-041B6AB5-65AD-402E-9C0A-198B4E6AF84C

Q38661895-7F6D25F7-05F4-463B-8788-09B2D95ED243

P932

Q38661895-B43454E3-8271-4DCA-917E-1803E94F6BDF

P356

S13045-017-0505-0

P1433

Journal of Hematology & Oncology

P1476

Recent developments in immunotherapy of acute myeloid leukemia.

@en

P2093

Christina Krupka

http://www.w3.org/2001/XMLSchema#string

Felix S Lichtenegger

http://www.w3.org/2001/XMLSchema#string

Marion Subklewe

http://www.w3.org/2001/XMLSchema#string

Sascha Haubner

http://www.w3.org/2001/XMLSchema#string

Thomas Köhnke

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

Antibody-drug conjugates as novel anti-cancer chemotherapeutics

Bispecific antibodies

Distribution and levels of cell surface expression of CD33 and CD123 in acute myeloid leukemia

Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia

Bispecific T-cell engaging antibodies for cancer therapy

Antibody drug conjugates: design and selection of linker, payload and conjugation chemistry

Redirecting Specificity of T cells Using the Sleeping Beauty System to Express Chimeric Antigen Receptors by Mix-and-Matching of VL and VH Domains Targeting CD123+ Tumors

Addition of gemtuzumab ozogamicin to induction chemotherapy in adult patients with acute myeloid leukaemia: a meta-analysis of individual patient data from randomised controlled trials.

Clinical overview of anti-CD19 BiTE(®) and ex vivo data from anti-CD33 BiTE(®) as examples for retargeting T cells in hematologic malignancies.

A CD3xCD123 bispecific DART for redirecting host T cells to myelogenous leukemia: preclinical activity and safety in nonhuman primates.

P2888

s13045-017-0505-0

P304

142

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13045-017-0505-0

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

10

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2017-07-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1090893244

http://www.w3.org/2001/XMLSchema#string

P698

28743264

http://www.w3.org/2001/XMLSchema#string

P921

acute myeloid leukemia

P932

5526264

http://www.w3.org/2001/XMLSchema#string